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ABSTRACT
Basophils and mast cells are effecter cells in allergenIgE-mediated immune responses. They induce type 1
immediate immune response in airway or other organ, resulting in bronchial asthma and other allergic dis-
eases. However, they also play a critical role in host defense against infection with helminthes. Upon linkage of
FcεRI with a complex of allergen and IgE, basophils and mast cells release a large amount of Th2 cytokines
and chemical mediators. Therefore these responses are “acquired allergic responses” and induce allergic dis-
eases, such as bronchial asthma. However, basophils and mast cells derived from cultured bone marrow cells
with IL-3 for 10 days express IL-18Rα chain and produce Th2 cytokines in response to the stimulation with IL-3
and IL-18 without FcεRI cross-linkage. Furthermore, they produce Th2 cytokines upon stimulation with several
TLR ligands, such as LPS. This finding may suggest the presence of allergenIgE-independent allergic re-
sponses, which we would like to designate asinnate allergic response”. However, in vivo treatment with IL-18
and IL-2 protects against gastrointestinal nematode infection by activating intestinal mucosal mast cells in
STAT6-independent manner, suggesting the importance of innate allergic response against helminth infection.
Here we discuss the functional role of IL-18-inducedinnate allergic response ” in disease and host defense.
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INTRODUCTION
IL-18 was discovered as a potent IFN-γ -inducing fac-
tor that is produced by macrophages and dendritic
cells upon stimulation with microbes or microbe
products.1 Thus, IL-18 has been categorized in an in-
nate immune cytokine. There are several pathways to
induce IFN-γ , a crucial factor for inflammatory re-
sponses . Th1 cells produce abundant IFN-γ in re-
sponse to the appropriate antigen. We now know that
a large amount of IFN-γ is also produced by a wide va-
riety of cell types in response to the innate immune
cytokines, such as IL-12, IL-15 and IL-18.2-8 IL-18 is
the first cytokines demonstrated to activate T cells to
produce plentiful IFN-γ without T cell receptor (TCR)
engagement.3,4 Resultant IFN-γ then activates macro-
phages to produce nitritic oxide,9 leading to eradica-
tion of intracellular pathogens,10-12 or tissue injuries
(Fig. 1).13 However, our recent studies also clarified
that IL-18 induce Th2 cytokines production from T
cells or mast cellsbasophils . 14,15 Without TCR en-
gagement, IL-18 with IL-2 induces T cells to produce
IL-4 and IL-13 and to express CD40 ligand, which in
combination induce B cell IgE response (Fig. 1). In-
deed, administration of IL-18 or IL-18 plus IL-2 into na
ve mice induces IgE in a CD4+ T cell- , IL-4- and
STAT6-dependent manner.15,16 Moreover, transgenic
mice over-expressing IL-18 in their keratinocytes ,
spontaneously produce IgE and develop atopic der-
matitis . 15-17 Intriguingly , this dermatitis develops
even in the absence of STAT6 activation, which is re-
quired for Th2 cell development and IgE responses.18
Thus, IL-18 induces dermatitis in an IgE-independent
manner. Antigen plus IgE induces allergic response
by activation of basophils and mast cells.19 However,
IL-18 induces allergic inflammation without Th2IgE.
Therefore, we proposed to designate the former type
asacquired allergic response” and the latter asin-
nate allergic response”(Fig. 2).8
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Fig. 1 Pleiotropic action of IL-18. IL-18 together with IL-12 stimulates various cels to produce significant amounts of 
IFN-γ, which activates macrophages to produce nitric oxide, leading to eradication of intracelular pathogens, like 
Leishmania major.  However, without IL-12, IL-18 promotes Th2 cytokines productions from T cels and basophils/ 
mast cels.  Thus, IL-18 regulates both Th1 and Th2 responses depending on its cytokine milieu.  The expulsion of 
some types of gastrointestinal nematodes depends on the action of Th2 responses, leading to the speculation of the 
protective roles of IL-18 against helminth infection. 
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IL-18-INDUCED ACTIVATION OF BASO-
PHILS AND MAST CELLS
It is well documented that basophils and mast cells
release a large amount of Th2 cytokines (IL-4, IL-5,
IL-9 and IL-13) after cross-linkage of their FcεRI by
antigen and antigen-specific IgE.19 IL-4 initiates and
promotes Th2 responses and is the most important
determinant of Ig class switching to IgE.20,21 IL-5 in-
duces maturation and activation of eosinophils.22 IL-
13 induce mucus production by causing goblet cell
hyperplasia. 23,24 Furthermore, IL-13 induces airway
hyperresponsiveness (AHR).25-28 Basophils and mast
cell also produce various bioactive chemical media-
tors such as histamine and lipid metabolites.19 Thus,
cross-linkage of FcεRI induces the development of
 acquired type allergic response ” . However , we
found that cultured bone marrow-derived basophils
and mast cells express IL-18Rα chain and produce IL-
4IL-13 and histamine in response to the stimulation
with IL-3 and IL-18 even without FcεRI cross-linkage. 14
Thus , IL-3 and IL-18 induce innate allergic re-
sponse” by direct activation of basophils and mast
cells (Fig. 2).
TOLL-LIKE RECEPTORS-MEDIATED ACTI-
VATION OF BASOPHILS AND MAST CELLS
The cytoplasmic portion of IL-18R is homologous to
that of Toll-like receptors (TLRs), which have been
identified as signaling receptor of the innate immune
system and recognize corresponding pathogen-
associated molecular patterns (PAMP).7,29 Myeloid
differentiation factor 88 (MyD88) is an adapter mole-
cule essential for signaling through either IL-18R or
TLRs . 30,31 Eleven mammalian TLRs have been de-
scribed so far and microbial ligands corresponding
each member have been identified.29 Upon entry of
invading pathogens , DCs recognize them through
TLRs and maturate to express co-stimulatory mole-
cules CD80 and CD86 and to produce IL-12.29 It is
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Fig. 2 IL-18-induced innate alergic response.  Alergen induces alergen-specific Th2 cels and the resultant alergen 
-specific IgE, which can activate efectors cels, such as basophils and mast cels, to induce alergic disorders. In contrast, 
IL-18-induced alergic disorders do not require Th2 cels or IgE. IL-18 stimulates basophils and mast cels to produce IL-4 
and IL-13 even without FcεRI cross-linkage.  CD4＋ T cels (NKT cels), stimulated with IL-2 and IL-18 without TCR en-
gagement express CD40 ligand and produce IL-4 and induce B cels to secrete IgE both in vitro and in vivo. Thus, we pro-
pose the former type be named “acquired alergic response”and the later named “innate alergic response”.
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widely accepted that IL-12 induces Th1 responses but
inhibits Th2 responses to achieve the efficient inflam-
matory responses.
IL-18 is secreted from various cells via activation of
TLRs after stimulation with microorganisms and their
products in a caspase-1-dependent manner . 32 Nota-
bly, upon stimulation via TLRs, IL-18 as well as other
proinflammatory cytokines including IL-12 are re-
leased.7 However, IL-12 does not block the activity of
IL-18-stimulated basophils or mast cells to produce
IL-4IL-13.14 Thus, basophils and mast cells produce
Th2 cytokines even under Th1-inducing condition.
Basophils and mast cells also produce Th2 cytoki-
nes via activation of TLRs on their cell surface with
PAMP . Mast cells produce Th 2 cytokines when
stimulated with ligands for TLR2 or TLR4, suggesting
their role in induction of Th2 response.33-36 TLR2 rec-
ognizes Gram-positive bacterial components, includ-
ing peptidoglycan (PGN) and lipoprotein, and TLR4
recognizes lipopolysaccharide (LPS), a component of
Gram-negative bacteria.29,37,38 Human basophils were
recently found to express high levels of TLR2 and
TLR4.39 More recently, it has been reported that hu-
man basophils produce Th2 cytokines when stimu-
lated with ligands for TLR2 but not TLR4, suggesting
that basophils can play an important role in promot-
ing and amplifying the Th2 responses . 40 Although
roles of TLRs on mast cells and human basophils
have been fully examined, expression and functional
roles of TLRs on murine basophils remain unclear.
We have recently revealed that bone marrow-derived
murine basophils selectively express TLR1, 2, 4 and 6
and produce significant amounts of Th2 cytokines
(IL-4, IL-6 and IL-13) in response to IL-3 plus PGN or
to IL-3 plus LPS via TLR2 or TLR4, respectively, even
without FcεRI cross-linkage (un-published observa-
tion) . Consistent with the previous reports,35 PGN-
or LPS-stimulated mast cells produce small amounts
of IL-6 and IL-13, which are significantly increased
when additionally stimulated with IL-3. However, no-
tably, compared with basophils, mast cells are poor
producers of IL-4 even when they were stimulated
with IL-3 and TLR ligands. Co-stimulation with IL-12
fails to attenuate these responses, substantiating fur-
ther that basophils favor induction of Th2 response. It
is known that allergic inflammatory responses are
also induced under some infectious condition . 41,42
Thus, our study suggests that bacterial components-
stimulated basophils may play a key role for induc-
tion ofinnate allergic responses”, providing a clue to
understanding the mechanisms of allergic diseases
triggered by bacterial infection (Fig. 3)
HELMINTH-INDUCED INTESTINAL MU-
COSAL MAST CELLS
It is well known the expulsion of some types of gas-
trointestinal nematodes depends on the action of Th2
responses. There are two types of Th2-mediated host
protective immunity against gastrointestinal nema-
tode infections. One is worm expulsion by activated
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Fig. 3 IL-18R- and TLR2/TLR-4 mediated Th2 cytokines
production from basophils. Basophils express both IL-18R α 
chain and TLRs. IL-18 and TLR ligand(s) stimulate basophils
through coresponding receptor and signaling through
adopter molecule, MyD88. 
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intestinal mast cells . 43 Strongyloides venezuelensis is
expelled by activated intestinal mast cells. The other
types of worm expulsion is mediated by mucus de-
rived from activated goblet cells stimulated by
IL-13. 44 Nippostrongy brasiliensis is expelled by this
mucous product (Fig. 4).
The role of intestinal mucosal mast cells (MMC) in
worm expulsion has been studied extensively in vari-
ous experimental host-parasite systems. In the case
of infection with Strongyloides venezuelensis (S. vene-
zuelensis) third-stage larvae (L3), host mice complete
parasite expulsion within 2 weeks, which is tightly as-
sociated with level of intestinal mastocytosis . 45,46
Therefore , mast cell-deficient WWv mice infected
with S. venezuelensis L3 show a significant delay in
parasite expulsion.45 Furthermore, parasite expulsion
is more severely impaired in WWv mice that are de-
ficient for IL-3 gene expression. In these mice, MMC
responses are almost completely absent and S. vene-
zuelensis continue to parasitize in the intestine for >50
days . 45 In the case of infection of mice with Tri-
chinella spiralis (T. spiralis) or Trichuris muris (T .
muris), IL-9 expression correlates well with the resis-
tant phenotype and its elevation in vivo results in the
enhancement of intestinal mastocytosis and parasite
expulsion.47,48 Furthermore, IL-9 transgenic mice that
display increased intestinal MMC more rapidly expel
T. muris or T. spiralis than wild-type mice.47,49 There-
fore, both IL-3 and IL-9 are deeply involved in recruit-
ment and activation of MMC in mice infected with
gastrointestinal nematode
It is well-established evidence that mouse mast cell
protease-1 (mMCP-1), selectively expressed by intes-
tinal MMC , participates in the effecter phase re-
sponse to intestinal nematodes expulsion . 43,50-53 In-
deed, mMCP-1-deficient mice fail to expel gastroin-
testinal nematode . 50 Miller et al. reported that
mMCP-1 is not detectable in the culture of bone
marrow-derived mast cells stimulated with IL-3
alone.9 However, mast cells begin to produce mMCP-
1 when additionally stimulated with IL-9, SCF and
TGF-β.9 Thus, it has been speculated that IL-3 and IL-
9 from Th2 cells in mice infected with gastrointestinal
nematode induce precursor cells to develop into
mMCP-1+MMC together with SCF and TGF-β from
gut epithelium
IL-18 PLUS IL-2-INDUCED INTESTINAL
MMCP-1+ MMC
As mentioned above, without TCR engagement, IL-18
with IL-2 can induce IL-4 and IL-13 production by
CD4+ T cells in vitro (Fig. 1).15 In addition to IL-4IL-
13, IL-18 plus IL-2 stimulates CD4+ T cells to produce
IL-3 and IL-9.16 Furthermore, administration of IL-18
plus IL-2 into nave mice induces increases in serum
levels of IL-3, IL-4, IL-9 and IL-13.16 As, IL-3, IL-4 and
IL-9 are well-known potent mast cell growth fac-
tors54-56 and essential to induce intestinal mMCP-1+
MMC,9 we tested whether daily administration of IL-2
andor IL-18 induces accumulation of MMC in intes-
tines of the mice, and found that IL-18 and IL-2 dose-
dependently increase the number of intestinal
MMC.57 Furthermore, these intestinal MMC express
mMCP-1, suggesting that they are activated.57 Taken
together, these results clearly indicate that treatment
with IL-18 and IL-2 induces accumulation, maturation
and activation of intestinal MMC, namely intestinal
mastocytosis (Fig. 5).
The cellular and molecular bases for IL-18 plus IL-
2-induced mMCP-1+MMC have been examined. Wild-
type mice depleted of CD4+ T cells by the pretreat-
ment with anti-CD 4 antibody or RAG-2 deficient
(RAG-2−−) mice, lacking both T cells and B cells, ex-
hibit poor accumulation of MMC in response to ad-
ministration of IL-18 plus IL-2, indicating a require-
ment of CD4+ T cells.57 Interestingly, STAT6−− mice
display intestinal mastocytosis when injected with IL-
2 and IL-18, suggesting STAT6-independent mastocy-
tosis.57 IL-18 plus IL-2-stimulated CD4+ T cells pro-
duce IL-3 and IL-9, well-known potent mast cell
growth factors.54,55 Indeed, administration of IL-3 and
IL-9 into nave mice for 2 weeks dose-dependently in-
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Fig. 4 Th2-mediated expulsion of gastrointestinal nematode.There are two types of Th2-mediated host 
protective immunity against gastrointestinal nematode infections. One is worm expulsion by activated intes-
tinal mast cels, which are developed from precursor cels stimulated with IL-3, IL-9 from Th2 cels and SCF 
and TGF-β from intestinal epithelial cels. Strongyloides venezuelensis is expeled by these activated mast 
cels. The other is worm expulsion by mucus from IL-13-stimulated goblet cels. Nippostrongy brasiliensis 
is expeled by this mucous product.  
Worm expulsion by
activated intestinal mucosal 
mast cells (MMC)
Nematode
Th2 Th2
MMC precursor
fibroblast or
MMC
IL-9
SCF
TGF-β
Worm expulsion by
 mucus from activated
goblet cells
mucin
goblet cells
mucin
Nematode
IL-13
IL-3
chondroitin sulfate
intestinal epithelial cells
ex. Strongyloides venezuelensis ex. Nippostrongylus brasiliensis
duce mMCP-1+MMC in the intestine . 57 Thus , IL-2
plus IL-18 treatment seems to induce mMCP-1+MMC
by virtue of IL-3 and IL-9 from CD4+ T cells and IL-3
seems to be most critical for mMCP-1+MMC induc-
tion (Fig. 5)
IL-18 PLUS IL-2-INDUCED INTESTINAL
MMC-DEPENDENT EXPULSION OF S .
VENEZUELENSIS
To examine the functional role of intestinal MMC in-
duced by IL-18 plus IL-2, we surgically implanted
adult worms in the duodenum of mice pretreated
with IL-2 andor IL-18 for 13 days and recovered in-
vading parasites at 16 h after implantation . 46 IL-18
plus IL-2-treated wild-type mice reject implanted
worms almost completely, while mice that received
PBS, IL-2 or IL-18 alone are heavily parasitized with
implanted worms (Fig . 5). However , mast cell-
deficient WWv mice even treated with IL-2 and IL-18
fail to reject them, indicating the rapid expulsion of
implanted adult worms is mediated by the function of
activated intestinal MMC.57 Importantly and as ex-
pected, IL-2 and IL-18-pretreated STAT6−− mice also
gain the capacity to rapidly reject implanted parasites.
These results taken together suggest that IL-18 with
IL-2 protects against gastrointestinal nematode infec-
tion by activating MMC-dependent innate type 2 im-
munity (Fig. 5)
ROLE OF ENDOGENOUS IL-18 FOR INDUC-
TION OF INTESTINAL MMC
Wild-type mice inoculated with S. venezuelensis L3
show a significant increase in serum levels of IL-18
(days 4 to 14), and complete worm expulsion within
12 days. Thus, to address the role of endogenous IL-
18 in the induction of intestinal MMC for the host de-
fense against S. venezuelensis L3 infection, the capac-
ity of IL-18−− mice or IL-18Rα −− mice to expel S.
venezuelensis was examined. Comparing to infected
wild-type mice, IL-18−− or IL-18Rα−− mice infected
with S. venezuelensis L3 exhibit significantly delayed
worm expulsion.57 Wild-type mice completed worm
expulsion by day 12, while IL-18−− or IL-18Rα−− mice
requested 16 days. However, they eventually expelled
infected parasites, suggesting the contribution of Th2
cells that were generated by parasite infection in IL-
18−− or IL-18Rα−− mice. Thus, we assume the possi-
ble contribution of Th2 cells to this late-phase induc-
tion of mMCP-1+MMC , namely worm expulsion .
These results taken together indicate involvement of
two types of intestinal MMC activation , IL-18-
dependent (innate type-2) MMC activation and Th2
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Fig. 5 IL-18 -induced intestinal MMC-dependent expulsion of S. venezuelensis.
In vivo treatment with IL-18 and IL-2 stimulates CD4＋ T cels to produce IL-3/IL-9, 
which develop precursor cels into mMCP-1＋MMC together with SCF and TGF-β 
from gut epithelium.  These activated mast cels promptly expel implanted adult S. 
venezuelensis by producing chondroitin sulfate, which interfere S. venezuelensis’ s
anchoring.
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Fig. 6  Colaboration between Th2 cel-dependent and IL-18-dependent mastocytosis for parasite 
expulsion. S. Venezuelensis expulsion might be induced by two types of intestinal mMCP-1＋MMC ac-
tivation, Th2 cels-dependent (acquired type-2) MMC activation and IL-2 and IL-18-dependent (innate 
type-2) MMC activation. 
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cells-dependent (acquired type-2) MMC activation for
S. venezuelensis expulsion (Fig. 6).
ROLE OF IL-18-DRIVEN IL-3 FOR INDUC-
TION OF BASOPHILS AND INTESTINAL
MMC
Although it is well known that IL-4 is critical to polari-
zation of CD4+ T cells to a Th2 phenotype, mainly in
vivo system, initial IL-4 producing cells in vivo are
poorly understood. Several cell types have been re-
ported to produce IL-4, including conventional CD4+
T cells,58,59 NKT cells60 and mast cells.61 It has been
reported that infection with gastrointestinal nema-
tode, Nippostrongylus brasiliensis (Nb) resulted in an
increase in the number of splenic FcεRI+, non-B, non-
T cells.62 Most of these FcεRI+ cells were basophils
morphologically and produced IL-4 in response to
FcεRI cross-linkage, suggesting that basophil-derived
IL-4 may play a physiologically important role in IgE
production.63 Recently, Paul and his colleagues have
more clearly demonstrated that Nb infection induces
substantial IL-4+ basophils in the lung , liver and
spleen in a STAT6 independent manner . 64 Recruit-
ment of basophils into these tissues is dependent on
CD4+ T cells.64 We have also observed that S. vene-
zuelensis infection induces substantial IL-4+ basophils
in the liver and spleen in a STAT6 independent man-
ner (unpublished data).
Nb-induced basophil recruitment and IL-4 produc-
tion has been partially inhibited by the treatment with
anti-IL-3 Ab.64 Glli and his colleagues have demon-
strated that IL-3 does enhance basophil accumulation
during S. venezuelensis infection.45 We suggested in
vivo IL-2 plus IL-18 treatment induces mMCP-1+
MMC via IL-3 and IL-9 production from CD4+ T
cells.57 Thus, infection with a parasite that induces a
Th2-type response” resulted in accumulation of tis-
sue basophils in the tissues, where basophils may act
as major IL-4-producing cells and protect host against
various pathogens by augmenting Th2 response (Fig.
5).
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